Skip to content

APOTHEEK INGE VERMEIREN

Active Private limited companyfounded 2008active for 17 yearsZeelaan 287, 8670 KoksijdeKBO/BCE: BE 0808.718.692 subsidiary of

Lifetime

17 annual accounts with figures on one time axis
peak of €177,542 in 2012
€161,649▲ 17.9%
lowest -€4,962 in 2015
€6,441▼ 91.8%
peak of €327,995 in 2025
€327,995▲ 2.0%
€243,287▲ 11.6%
peak of 1.5 FTE in 2011
1.2 FTE 
Board1 name since 2019
1 director
Owners
99.96%
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Gross margin from €137,134 to €161,649Result from €79,027 to €6,441Cash from €57,442 to €75,249

Key points

from the 2025 annual accounts

Equity

€327,995 ▲ 2.0%

APOTHEEK INGE VERMEIREN has made a profit without a break since 2018.

Result

€6,441 ▼ 91.8%
€79,0002024€6,4402025

The result fell in 2025 from €79,027 to €6,441.

Filings

17 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

Ten of the last ten came late. The 2019 accounts came in latest, 34 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 10,916 companies had the same profile as APOTHEEK INGE VERMEIREN has now. Each dot stands for 28 companies, two years later.

95.1%
were still trading
4.1%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 10,916 companies, not a prediction for APOTHEEK INGE VERMEIREN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
  • 99.96%score equity €449,274 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0808718692
Company renamed from APOTHEEK ANNE SAELEN to APOTHEEK INGE VERMEIREN changes role from manager to director · resigns as statutory manager · acts as permanent representative · General meeting of 25-11-2019 · Gazette deed
New manager appointed, resigned · acts as permanent representative · General meeting of 31-05-2019 · Gazette deed
Capital decrease of €251,400 to €18,600 The capital fell from €270,000 to €18,600 · General meeting of 22-06-2015 · Gazette deed
All 28 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK INGE VERMEIREN Koksijde €571,282 €161,649 57.4% 1.2
LO-PHARMA Lubbeek €597,566 €150,129 13.2% 1.3
APOTHEEK AMPE Kortrijk €558,220 €152,019 34.8% 1
APOTHEEK SINT-LODEWIJK Deerlijk €472,157 €171,496 75.9% 1
APOTHEEK TAMPERE Ostend €457,212 €173,561 48.2% 1
APOTHEEK VIRO Wervik €649,766 €211,002 69.2% 1.2
APOTHEEK AERNOUT Tielt €688,443 €185,506 65.4% 1

These companies have the same main activity as APOTHEEK INGE VERMEIREN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €457,000 and €688,000, founded between 2006 and 2009.

Official details

Source: KBO
Status
Active since 26-12-2008Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.175.524.2158670 Koksijde, since 01-01-2009
Financial year end
31 December
Peppol
Reachable since 10-10-2025
Company details

Annual accounts 2025

≈ €760,000estimated
€571,282▲ 5.9%
Employeeson 31-12-2025
2
Filing
Filed on 31-08-2026
Financials

Insights on APOTHEEK INGE VERMEIREN

APOTHEEK INGE VERMEIREN files the abbreviated format. That format states no turnover. The gross margin fell from €165,746 in 2009 to €161,649 in 2025.

The balance sheet grew most from 2019 to 2021 through fixed assets.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK INGE VERMEIREN

What is the company number of APOTHEEK INGE VERMEIREN?
The company number of APOTHEEK INGE VERMEIREN is 0808.718.692. The VAT number is the same number with BE in front: BE 0808.718.692.
Where is APOTHEEK INGE VERMEIREN based?
The registered office is at Zeelaan 287, 8670 Koksijde.Company details
What does APOTHEEK INGE VERMEIREN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK INGE VERMEIREN?
APOTHEEK INGE VERMEIREN is a private limited company (BV).
When was APOTHEEK INGE VERMEIREN founded?
APOTHEEK INGE VERMEIREN was founded on 26-12-2008.
Is APOTHEEK INGE VERMEIREN still active?
Yes, APOTHEEK INGE VERMEIREN is an active enterprise in the KBO register.
How many employees does APOTHEEK INGE VERMEIREN have?
APOTHEEK INGE VERMEIREN had an average of 1.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK INGE VERMEIREN?
The turnover in financial year 2025 is about €760,000. This figure is estimated from the gross margin of €161,649 and 43 comparable companies (NACE 477). It probably lies between €500,000 and €1.6m.
Is APOTHEEK INGE VERMEIREN profitable?
In financial year 2025, APOTHEEK INGE VERMEIREN made a profit of €6,441.
Where can I find the annual accounts of APOTHEEK INGE VERMEIREN?
APOTHEEK INGE VERMEIREN filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK INGE VERMEIREN due?
APOTHEEK INGE VERMEIREN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.